The content on this site is intended for healthcare professionals only
Prof Deborah Fenlon talks to ecancer about a study reviewing laser therapy for vulvo-vaginal atrophy (VVA) or genito-urinary syndrome of menopause (GSM) in breast cancer survivors.
She explains that when women undergo the menopause they can develop VVA which can leave them vulnerable to vaginal and urinary tract infections.
As chemotherapy and other therapies can knock out the ovaries, this can lead to an early menopause and therefore leave cancer survivors subject to infections.
Prof Fenlon explains that the laser treatment removes very fine layers of skin from the vagina, stimulating new growth and helping it become healthier.
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
Tisotumab vedotin shows clinically meaningful OS improvement versus chemo for metastatic cervical cancer
A reproducibility study in pulmonary adenocarcinomas supports a revised classification
Reducing stigma for lung cancer and other smoking-related respiratory diseases
Assessment of QoL results and correlation with survival outcomes in phase III clinical trials in metastatic NSCLC
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer
Gemcitabine, cisplatin plus nivolumab achieves clinical complete response in subset of muscle-invasive bladder cancer patients
The role of multidisciplinary tumour board in managing stage 3 lung cancer
Cancer pain management
